의약품용 막 여과 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of pharmaceutical membrane filtration Market

The global pharmaceutical membrane filtration market size was valued at USD 5.11 billion in 2025 and is projected to grow from USD 5.49 billion in 2026 to USD 11.05 billion by 2034, exhibiting a CAGR of 9.15% during the forecast period. North America dominated the market with a 42.27% share in 2025, supported by strong biopharmaceutical manufacturing, increasing biologics production, and rising demand for advanced purification technologies.

Pharmaceutical membrane filtration is an essential separation and purification technology used to ensure product sterility, clarity, and quality. It is widely applied in biologics, biosimilars, vaccines, cell and gene therapies, and injectable drug manufacturing. Increasing investments in biopharmaceutical capacity and the adoption of single-use technologies are creating strong demand for advanced filtration solutions.

Market Definition and Scope

The market includes membrane filters, filtration systems, and consumables, with technologies such as microfiltration, ultrafiltration, nanofiltration, and others. Major applications include final product processing, raw material filtration, virus filtration, and cell separation. End users include pharmaceutical and biotechnology companies, CROs and CDMOs, and academic and research institutes.

Market Dynamics

Driver: The rapid expansion of biologics and biosimilars manufacturing is a major growth factor. Biologics require extensive filtration during purification and sterile processing, increasing demand for high-performance membrane systems.

Restraint: High capital and operational costs can restrict adoption, particularly among smaller manufacturers and companies in developing markets. Advanced UF/DF and high-capacity filtration systems require substantial investment.

Opportunity: Expanding biopharmaceutical manufacturing capacity in Asia Pacific is creating significant opportunities. China, India, South Korea, and Singapore are developing biologics facilities, vaccine plants, CDMOs, and advanced bioprocessing infrastructure.

Trend: Increasing adoption of single-use technologies is transforming pharmaceutical filtration. Disposable and pre-assembled filtration systems reduce contamination risks and improve operational flexibility compared with traditional reusable systems.

Challenge: Slow adoption of advanced filtration technologies in developing regions remains a challenge due to high costs, limited technical expertise, and supply-chain constraints.

Segmentation Analysis

By product, membrane filters held the largest share in 2025, supported by increasing demand for sterilization-grade filtration. However, filtration systems are expected to record the fastest growth, with a CAGR of 9.83%.

By technique, microfiltration dominated and is projected to account for 43.9% in 2026, owing to its extensive use throughout bioprocessing workflows. Nanofiltration is expected to grow at a CAGR of 9.81%.

By usage, single-use products dominated and are expected to hold a 55.3% share in 2026. By scale, commercial manufacturing is projected to account for 51.0% in 2026. By application, final product processing is expected to lead with a 39.8% share in 2026, while virus filtration is projected to grow at a CAGR of 11.73%.

By end user, pharmaceutical and biotechnology companies are expected to maintain their leading position with a 59.3% share in 2026. CROs and CDMOs are projected to grow at a CAGR of 12.31%.

Regional Insights

North America led the market with USD 2.16 billion in 2025, representing 42.27% of the global market. The U.S. is projected to reach USD 2.14 billion in 2026, supported by extensive biologics and biosimilars manufacturing.

Europe is projected to reach USD 1.47 billion in 2026, growing at a CAGR of 8.80%. The U.K., Germany, and France are expected to reach USD 0.33 billion, USD 0.30 billion, and USD 0.24 billion, respectively.

Asia Pacific is expected to reach USD 1.26 billion in 2026, with China and India projected at USD 0.39 billion and USD 0.23 billion, respectively. Latin America is expected to reach USD 0.25 billion, while the GCC recorded USD 0.08 billion in 2025.

Competitive Landscape

Major companies include Danaher, Merck KGaA, Sartorius, 3M, Repligen, Parker Hannifin, Eaton, Thermo Fisher Scientific, Cytiva, and Avantor. Companies are focusing on strategic acquisitions, collaborations, manufacturing expansion, automation, and single-use filtration technologies to strengthen their portfolios.

Report Coverage

The report covers market size and forecast, segmentation, market dynamics, regional analysis, technological advancements, product developments, mergers and acquisitions, strategic initiatives, and competitive profiles of leading market participants.

Conclusion

The global pharmaceutical membrane filtration market is projected to expand from USD 5.11 billion in 2025 to USD 11.05 billion by 2034, supported by growing biologics and biosimilars production, increasing adoption of single-use technologies, and expanding biopharmaceutical manufacturing capacity. Advanced filtration systems, virus filtration, and CDMO expansion are creating additional opportunities, while high investment costs and slower technology adoption in developing markets remain important challenges.

Global Pharmaceutical Membrane Filtration Market Scope

Segmentation By Products

• Membrane Filters
  • Polyethersulfone (PES) Filters
  • Polyvinylidene Fluoride (PVDF) Filters
  • Polytetrafluoroethylene (PTFE) Filters
  • Nylon Filters
  • Others
• Filtration Systems
• Consumables & Others

By Technique

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Others

By Usage

• Single Use
• Reusable

By Scale

• R&D Scale
• Pilot-scale
• Commercial Scale

By Application

• Final Product Processing
• Raw Material Filtration
• Virus Filtration
• Cell Separation
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• CROs & CDMOs
• Academic & Research Institutes
• Others

By Geography

• North America (By Products, Technique, Usage, Scale, Application, End User, and Country)
  • U.S.
  • Canada
• Europe (By Products, Technique, Usage, Scale, Application, End User, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Products, Technique, Usage, Scale, Application, End User, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Products, Technique, Usage, Scale, Application, End User, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Products, Technique, Usage, Scale, Application, End User, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Key Industry Developments - Mergers, Acquisitions, and Partnerships, among others
• 4.2. Technological Advancements in Pharmaceutical Membrane Filtration
• 4.3. New Product Launches, By Key Players
• 4.4. Regulatory Scenario, By Key Countries/Region
• 4.5. Key Start-ups in the Market

5. Global Pharmaceutical Membrane Filtration Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Products
  • 5.1.1. Membrane Filters
    • 5.1.1.1. Polyethersulfone (PES) Filters
    • 5.1.1.2. Polyvinylidene Fluoride (PVDF) Filters
    • 5.1.1.3. Polytetrafluoroethylene (PTFE) Filters
    • 5.1.1.4. Nylon Filters
    • 5.1.1.5. Others
  • 5.1.2. Filtration Systems
  • 5.1.3. Consumables & Others
• 5.2. Market Analysis, Insights and Forecast - By Technique
  • 5.2.1. Microfiltration
  • 5.2.2. Ultrafiltration
  • 5.2.3. Nanofiltration
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Usage
  • 5.3.1. Single Use
  • 5.3.2. Reusable
• 5.4. Market Analysis, Insights and Forecast - By Scale
  • 5.4.1. R&D Scale
  • 5.4.2. Pilot-scale
  • 5.4.3. Commercial Scale
• 5.5. Market Analysis, Insights and Forecast - By Application
  • 5.5.1. Final Product Processing
  • 5.5.2. Raw Material Filtration
  • 5.5.3. Virus Filtration
  • 5.5.4. Cell Separation
  • 5.5.5. Others
• 5.6. Market Analysis, Insights and Forecast - By End User
  • 5.6.1. Pharmaceutical & Biotechnology Companies
  • 5.6.2. CROs & CDMOs
  • 5.6.3. Academic & Research Institutes
  • 5.6.4. Others
• 5.7. Market Analysis, Insights and Forecast - Region
  • 5.7.1. North America
  • 5.7.2. Europe
  • 5.7.3. Asia Pacific
  • 5.7.4. Latin America
  • 5.7.5. Middle East & Africa

6. North America Pharmaceutical Membrane Filtration Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Products
  • 6.1.1. Membrane Filters
    • 6.1.1.1. Polyethersulfone (PES) Filters
    • 6.1.1.2. Polyvinylidene Fluoride (PVDF) Filters
    • 6.1.1.3. Polytetrafluoroethylene (PTFE) Filters
    • 6.1.1.4. Nylon Filters
    • 6.1.1.5. Others
  • 6.1.2. Filtration Systems
  • 6.1.3. Consumables & Others
• 6.2. Market Analysis, Insights and Forecast - By Technique
  • 6.2.1. Microfiltration
  • 6.2.2. Ultrafiltration
  • 6.2.3. Nanofiltration
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Usage
  • 6.3.1. Single Use
  • 6.3.2. Reusable
• 6.4. Market Analysis, Insights and Forecast - By Scale
  • 6.4.1. R&D Scale
  • 6.4.2. Pilot-scale
  • 6.4.3. Commercial Scale
• 6.5. Market Analysis, Insights and Forecast - By Application
  • 6.5.1. Final Product Processing
  • 6.5.2. Raw Material Filtration
  • 6.5.3. Virus Filtration
  • 6.5.4. Cell Separation
  • 6.5.5. Others
• 6.6. Market Analysis, Insights and Forecast - By End User
  • 6.6.1. Pharmaceutical & Biotechnology Companies
  • 6.6.2. CROs & CDMOs
  • 6.6.3. Academic & Research Institutes
  • 6.6.4. Others
• 6.7. Market Analysis, Insights and Forecast - By Country
  • 6.7.1. U.S.
  • 6.7.2. Canada

7. Europe Pharmaceutical Membrane Filtration Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Products
  • 7.1.1. Membrane Filters
    • 7.1.1.1. Polyethersulfone (PES) Filters
    • 7.1.1.2. Polyvinylidene Fluoride (PVDF) Filters
    • 7.1.1.3. Polytetrafluoroethylene (PTFE) Filters
    • 7.1.1.4. Nylon Filters
    • 7.1.1.5. Others
  • 7.1.2. Filtration Systems
  • 7.1.3. Consumables & Others
• 7.2. Market Analysis, Insights and Forecast - By Technique
  • 7.2.1. Microfiltration
  • 7.2.2. Ultrafiltration
  • 7.2.3. Nanofiltration
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Usage
  • 7.3.1. Single Use
  • 7.3.2. Reusable
• 7.4. Market Analysis, Insights and Forecast - By Scale
  • 7.4.1. R&D Scale
  • 7.4.2. Pilot-scale
  • 7.4.3. Commercial Scale
• 7.5. Market Analysis, Insights and Forecast - By Application
  • 7.5.1. Final Product Processing
  • 7.5.2. Raw Material Filtration
  • 7.5.3. Virus Filtration
  • 7.5.4. Cell Separation
  • 7.5.5. Others
• 7.6. Market Analysis, Insights and Forecast - By End User
  • 7.6.1. Pharmaceutical & Biotechnology Companies
  • 7.6.2. CROs & CDMOs
  • 7.6.3. Academic & Research Institutes
  • 7.6.4. Others
• 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.7.1. U.K.
  • 7.7.2. Germany
  • 7.7.3. France
  • 7.7.4. Italy
  • 7.7.5. Spain
  • 7.7.6. Scandinavia
  • 7.7.7. Rest of Europe

8. Asia Pacific Pharmaceutical Membrane Filtration Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Products
  • 8.1.1. Membrane Filters
    • 8.1.1.1. Polyethersulfone (PES) Filters
    • 8.1.1.2. Polyvinylidene Fluoride (PVDF) Filters
    • 8.1.1.3. Polytetrafluoroethylene (PTFE) Filters
    • 8.1.1.4. Nylon Filters
    • 8.1.1.5. Others
  • 8.1.2. Filtration Systems
  • 8.1.3. Consumables & Others
• 8.2. Market Analysis, Insights and Forecast - By Technique
  • 8.2.1. Microfiltration
  • 8.2.2. Ultrafiltration
  • 8.2.3. Nanofiltration
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Usage
  • 8.3.1. Single Use
  • 8.3.2. Reusable
• 8.4. Market Analysis, Insights and Forecast - By Scale
  • 8.4.1. R&D Scale
  • 8.4.2. Pilot-scale
  • 8.4.3. Commercial Scale
• 8.5. Market Analysis, Insights and Forecast - By Application
  • 8.5.1. Final Product Processing
  • 8.5.2. Raw Material Filtration
  • 8.5.3. Virus Filtration
  • 8.5.4. Cell Separation
  • 8.5.5. Others
• 8.6. Market Analysis, Insights and Forecast - By End User
  • 8.6.1. Pharmaceutical & Biotechnology Companies
  • 8.6.2. CROs & CDMOs
  • 8.6.3. Academic & Research Institutes
  • 8.6.4. Others
• 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.7.1. China
  • 8.7.2. Japan
  • 8.7.3. India
  • 8.7.4. Australia
  • 8.7.5. Southeast Asia
  • 8.7.6. Rest of Asia Pacific

9. Latin America Pharmaceutical Membrane Filtration Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Products
  • 9.1.1. Membrane Filters
    • 9.1.1.1. Polyethersulfone (PES) Filters
    • 9.1.1.2. Polyvinylidene Fluoride (PVDF) Filters
    • 9.1.1.3. Polytetrafluoroethylene (PTFE) Filters
    • 9.1.1.4. Nylon Filters
    • 9.1.1.5. Others
  • 9.1.2. Filtration Systems
  • 9.1.3. Consumables & Others
• 9.2. Market Analysis, Insights and Forecast - By Technique
  • 9.2.1. Microfiltration
  • 9.2.2. Ultrafiltration
  • 9.2.3. Nanofiltration
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Usage
  • 9.3.1. Single Use
  • 9.3.2. Reusable
• 9.4. Market Analysis, Insights and Forecast - By Scale
  • 9.4.1. R&D Scale
  • 9.4.2. Pilot-scale
  • 9.4.3. Commercial Scale
• 9.5. Market Analysis, Insights and Forecast - By Application
  • 9.5.1. Final Product Processing
  • 9.5.2. Raw Material Filtration
  • 9.5.3. Virus Filtration
  • 9.5.4. Cell Separation
  • 9.5.5. Others
• 9.6. Market Analysis, Insights and Forecast - By End User
  • 9.6.1. Pharmaceutical & Biotechnology Companies
  • 9.6.2. CROs & CDMOs
  • 9.6.3. Academic & Research Institutes
  • 9.6.4. Others
• 9.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.7.1. Brazil
  • 9.7.2. Mexico
  • 9.7.3. Rest of Latin America

10. Middle East & Africa Pharmaceutical Membrane Filtration Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Products
  • 10.1.1. Membrane Filters
    • 10.1.1.1. Polyethersulfone (PES) Filters
    • 10.1.1.2. Polyvinylidene Fluoride (PVDF) Filters
    • 10.1.1.3. Polytetrafluoroethylene (PTFE) Filters
    • 10.1.1.4. Nylon Filters
    • 10.1.1.5. Others
  • 10.1.2. Filtration Systems
  • 10.1.3. Consumables & Others
• 10.2. Market Analysis, Insights and Forecast - By Technique
  • 10.2.1. Microfiltration
  • 10.2.2. Ultrafiltration
  • 10.2.3. Nanofiltration
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Usage
  • 10.3.1. Single Use
  • 10.3.2. Reusable
• 10.4. Market Analysis, Insights and Forecast - By Scale
  • 10.4.1. R&D Scale
  • 10.4.2. Pilot-scale
  • 10.4.3. Commercial Scale
• 10.5. Market Analysis, Insights and Forecast - By Application
  • 10.5.1. Final Product Processing
  • 10.5.2. Raw Material Filtration
  • 10.5.3. Virus Filtration
  • 10.5.4. Cell Separation
  • 10.5.5. Others
• 10.6. Market Analysis, Insights and Forecast - By End User
  • 10.6.1. Pharmaceutical & Biotechnology Companies
  • 10.6.2. CROs & CDMOs
  • 10.6.3. Academic & Research Institutes
  • 10.6.4. Others
• 10.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.7.1. GCC
  • 10.7.2. South Africa
  • 10.7.3. Rest of the Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Danaher Corporation
  • 11.2.2. Merck KGaA,
  • 11.2.3. Sartorius AG
  • 11.2.4. 3M
  • 11.2.5. Repligen Corporation
  • 11.2.6. Parker Hannifin Corp
  • 11.2.7. Eaton
  • 11.2.8. Thermo Fisher Scientific Inc.
  • 11.2.9. Avantor, Inc.
  • 11.2.10. Biopharma Filters